Some clinical presentations can occur in association with medications or following certain infectious diseases. The IMA takes these syndromes seriously, evaluates them based on current scientific evidence, and carefully differentiates between them.
Post-finasteride syndrome (PFS) describes a spectrum of persistent sexual, neuropsychiatric, and somatic symptoms that may occur after discontinuation of finasteride and can persist beyond the expected pharmacological duration of action.
Persistent symptoms following SARS-CoV-2 infection (Long COVID / Post-COVID syndrome) as well as following COVID-19 vaccination (Post-Vac syndrome) represent a growing medical challenge.
Persistent fatigue and exertional symptoms can have a variety of underlying causes. Clear differentiation is medically essential to avoid misclassification, overdiagnosis, or underdiagnosis.
Post-SSRI syndrome (PSSD) describes persistent sexual dysfunction that may continue after discontinuation of selective serotonin reuptake inhibitors (SSRIs).